(A96) Arenaviral haemorrhagic fever

More details coming soon

Icon
929 in individuals diagnosis arenaviral haemorrhagic fever confirmed

Diagnosis arenaviral haemorrhagic fever is diagnosed Women are 25.30% more likely than Men

347

Men receive the diagnosis arenaviral haemorrhagic fever

0 (less than 0.1%)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
582

Women receive the diagnosis arenaviral haemorrhagic fever

0 (less than 0.1%)

Died from this diagnosis.

Risk Group for the Disease arenaviral haemorrhagic fever - Men aged 80-84 and Women aged 65-69

Icon
In Men diagnosis is most often set at age 80-84
Icon
Less common in men the disease occurs at Age 0-79, 85-95+Less common in women the disease occurs at Age 0-64, 70-74, 80-95+
Icon
In Women diagnosis is most often set at age 65-69, 75-79

Disease Features arenaviral haemorrhagic fever

Icon
Absence or low individual and public risk
Icon

Arenaviral haemorrhagic fever - what does this mean

Arenaviral haemorrhagic fever is a viral infection caused by a family of viruses known as arenaviridae. it is spread through contact with infected rodents or their excreta, and can also be transmitted from person to person through direct contact with infected bodily fluids. symptoms include fever, headache, muscle pain, and bleeding, and can be fatal if left untreated.

What happens during the disease - arenaviral haemorrhagic fever

Arenaviral haemorrhagic fever is caused by a group of viruses from the arenaviridae family. these viruses are transmitted to humans through contact with the excretions of infected rodents, such as urine and saliva. once inside the body, the virus replicates in the cells of the immune system, causing an acute inflammatory response and leading to a range of symptoms, including fever, headache, muscle ache, nausea, vomiting, abdominal pain, and bleeding. in some cases, the infection can be fatal.

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Blood tests for antibodies and antigens
  • Imaging tests (CT scan, MRI, etc.)
  • Liver function tests
  • Kidney function tests
  • Urine tests
  • Stool tests
  • Tissue biopsies
  • Viral culture tests
  • Polymerase chain reaction (PCR) tests

Treatment and Medical Assistance

Main goal of the treatment: To reduce the severity of symptoms and prevent complications.
  • Administer antiviral medications to reduce viral load.
  • Provide supportive care, such as hydration and electrolyte management.
  • Provide oxygen therapy to maintain normal oxygen levels in the blood.
  • Administer antibiotics to prevent secondary bacterial infections.
  • Administer blood transfusions to replace lost blood.
  • Administer pain medications to reduce discomfort.
  • Provide nutritional support to prevent malnutrition.
  • Provide psychological support to reduce stress and anxiety.
  • Monitor vital signs closely to detect any changes.
  • Provide education about the disease and its treatment.
Icon
10 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Arenaviral haemorrhagic fever - Prevention

To prevent arenaviral haemorrhagic fever, it is important to avoid contact with rodents, especially those in areas where the disease is known to exist, and to practice good hygiene and sanitation. it is also important to avoid contact with people who have the disease or have been exposed to it. vaccines are available for some types of arenaviral haemorrhagic fever, and these should be considered for those at high risk.

Specified forms of the disease

(A96.0) Junin haemorrhagic fever
(A96.1) Machupo haemorrhagic fever
(A96.2) Lassa fever
(A96.8) Other arenaviral haemorrhagic fevers
(A96.9) Arenaviral haemorrhagic fever, unspecified